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Objective: With an incidence up to 63 per 100,000 live births, perinatal stroke is an
important cause of childhood epilepsy. The aim of the study was to find the prevalence
of and predictive factors for epilepsy, and to describe the course of epilepsy in children
with perinatal strokewith different vascular subtypes.
Methods: Patients were retrieved from the Estonian Paediatric Stroke Database with
follow-up time at least 24 months. Patients were divided into 5 perinatal stroke syn-
dromes: neonatal arterial ischemic stroke (AIS), neonatal hemorrhagic stroke, neona-
tal cerebral sinovenous thrombosis, presumed AIS, and presumed periventricular
venous infarction.
Results: The final study group included 73 children with perinatal stroke (39 boys).
With a median follow-up time of 8.6 years, epilepsy was diagnosed in 21/73 (29%) chil-
dren, most of whom had AIS (17/21, 81%). The 18-year cumulative poststroke epilepsy
risk according to the Kaplan-Meier estimator was 40.8% (95% confidence interval [CI]
20.7–55.9%). The median age at epilepsy diagnosis was 50 months (range 1 month to
18.4 years). Children with neonatal AIS had the highest risk of epilepsy, but children
with presumed AIS more often had severe epilepsy syndromes. Cortical lesions (odds
ratio [OR] 19.7, 95% CI 2.9–133), and involvement of thalamus (OR 9.8, 95% CI 1.8–
53.5) and temporal lobe (OR 8.3, 95% CI 1.8–39.6) were independently associated with
poststroke epilepsy.
Significance: The risk for poststroke epilepsy after perinatal stroke depends on the
vascular subtype. Patients with perinatal AIS need close follow-up to detect epilepsy
and start with antiepileptic treatment on time.
KEY WORDS: Perinatal stroke, Neonatal stroke, Neonatal intracerebral hemor-
rhage, Presumed perinatal stroke, Periventricular venous infarction, Poststroke epi-
lepsy.
With an incidence of 13–63 per 100,000 live births,1,2
perinatal stroke in an important cause of childhood epilepsy.
By a consensus document, perinatal stroke can occur from
the 20th week of gestation through the 28th day after birth.3
According to the time of diagnosis and the vascular lesion
type, Kirton and deVeber have described 5 main subtypes of
perinatal stroke: neonatal arterial ischemic stroke (AIS),
neonatal arterial hemorrhagic stroke (HS), neonatal cerebral
sinovenous thrombosis (CSVT), presumed AIS, and pre-
sumed periventricular venous infarction (PVI).4,5
Children with perinatal stroke may develop long-term
disabilities including motor and somatosensory deficits, epi-
lepsy, and language, cognitive, and behavioral disorders,5
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depending on the vascular subtype of the stroke.4,6 The out-
come after neonatal AIS is most thoroughly studied; far less
is known about the effect of the other perinatal stroke sub-
types on a child’s neurodevelopment. Rates of epilepsy after
perinatal stroke vary largely due to different inclusion crite-
ria and various periods of observation. Previous studies
have shown that epilepsy develops in 21–67% of children
with neonatal AIS,1,7–13 in 3% of children with neonatal
AHS,14 in 17–41% of children with neonatal CSVT,15 in
13–41% of children with presumed AIS,10,13,16,17 and in
23% of children with presumed PVI.18 Some studies have
not found any predictive factors for epilepsy after perinatal
stroke,11,16 but others have shown that cortical lesions,4
large stroke size,12 involvement of the right middle cerebral
artery or multiple territories,19 and neonatal seizures13 may
predict remote seizures.
The aim of the study was to find the prevalence and pre-
dictive factors of epilepsy, and to describe the course of epi-
lepsy in children with perinatal stroke with different
vascular subtypes.
Methods
Patients were retrieved from the Estonian Paediatric
Stroke Database. All children with pediatric stroke trea-
ted at the Children’s Clinic of Tartu University Hospital
have been included in the database: retrospectively dur-
ing the epidemiological study (1994–2003)2 and
prospectively thereafter. There are 2 tertiary children’s
hospitals with pediatric neurology departments in Esto-
nia. Children living in the southern and eastern parts of
Estonia are treated mainly at Tartu University Hospital
and children from the northern and western parts of
Estonia are treated at Tallinn Children’s Hospital.
Therefore, the Estonian Paediatric Stroke Database
includes the majority of pediatric stroke cases from the
southern and eastern parts of Estonia, but patients from
the rest of Estonia are included randomly. On January
1st, 2016, there were 83 children with perinatal stroke
in the database.
Inclusion criteria were the following: (1) neuroradiologi-
cally proven diagnosis of stroke by magnetic resonance
imaging (MRI) or computed tomography (CT); (2) children
with one of the 5 perinatal stroke syndromes; (3) follow-up
time of at least 24 months; (4) without concomitant brain
anomaly with increased risk for epilepsy. Ten children were
excluded from the study: 5 children because of a short fol-
low-up period, one severely disabled child with a chromoso-
mal defect with increased risk for epilepsy, 3 children with
antenatal stroke, and one child with presumed arterial hem-
orrhagic stroke.
Data abstraction
Medical records of patients were reviewed for relevant
data: pregnancy and birth history, symptoms at stroke pre-
sentation, age at the diagnosis of epilepsy, seizure semiol-
ogy, antiepileptic treatment, seizure control, presence of
convulsive status epilepticus (SE), and electrical status
epilepticus in sleep (ESES).
The neuroradiological images of patients in the Esto-
nian Paediatric Stroke Database have been archived in
the All-Estonian Digital Picture Archiving System.
Before inclusion in the database, images have been ree-
valuated by 3 radiologists6 and the vascular type of the
stroke was established according to Kirton and deVe-
ber.4,5 Neonatal HS included the following: (1) intra-
parenchymal hemorrhage, (2) subarachnoid hemorrhage,
and (3) intraventricular stage III hemorrhage in a term
newborn without definable pathogenic factors.20 PVI
was defined as an infarction of the periventricular
white matter in the medullary venous territory.4 Stroke
size was graded according to the number of involved
cerebral lobes: (1) small lesion: focal ventricular dilata-
tion, periventricular or cortical damage involving one
cerebral lobe only; and (2) large lesion: multiple lobes
involved.6 The location of stroke was specified by the
involvement of basal ganglia, thalamus, cerebral lobes
(frontal, parietal, temporal, and occipital), and cerebel-
lum.
The diagnosis of neonatal seizures was made clinically.
During the study period, only conventional 1-hour 10/20
montage electroencephalography (EEG) was used to con-
firm neonatal seizures. Epileptiform activity on EEG was
defined as sudden, repetitive, evolving, and stereotyped epi-
sodes of abnormal electrographic activity with an amplitude
of at least 2 lV and a minimum duration of 10 seconds.21
Epilepsy was diagnosed by the treating pediatric neurolo-
gist according to the definition: at least 2 unprovoked sei-
zures occurring >24 h apart or one unprovoked seizure with
high recurrence risk, or diagnosis of an epilepsy syn-
drome.22 Due to a high recurrence risk of seizures in cases
with preexisting brain lesions,22 as in the case of perinatal
stroke, epilepsy was often diagnosed after the first epileptic
seizure if the EEG was supportive. Within the total cohort,
postneonatal EEG was performed in 52/73 (71%) children.
Key Points
• The risk for poststroke epilepsy after perinatal stroke
depends on vascular subtype
• Children with neonatal AIS have the highest risk for
poststroke epilepsy
• Lesions located in cortex, thalamus, and/or temporal
lobe are most significantly associated with onset of
poststroke epilepsy
• Patients with perinatal stroke, especially with AIS,
need close follow-up until adulthood to detect epi-
lepsy
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Because the risk of epilepsy in children with epileptiform
discharges with preexisting brain lesion but without clinical
seizures is unclear, these cases were solved individually.
ESES was diagnosed as a typical EEG pattern of sleep-
induced spikes and waves with a frequency of 1.5–3.5 Hz
occupying at least 85% of slow sleep.23 ESES spectrum dis-
order was defined when the spike and wave index (SWI) in
the EEG was between 50% and 84%.24 EEG findings of the
patients were reviewed by the clinical neurophysiologist
(U.V.), and the presence of epileptiform activity was
described and SWI was counted.
The course of epilepsy was classified according to a mod-
ified version of the Engel classification:11 Class 0, seizure-
free and off anticonvulsants for at least 6 months; class 1,
seizure-free for at least 6 months while on medication or
seizure-free off medication for fewer than 6 months; class
2, on medication, fewer than one seizure a month; class 3,
one to 4 seizures a month; class 4, 5 to 30 seizures a month;
and class 5, 30 or more seizures a month. Active seizures
were defined as modified Engel class 2 or higher. Drug-
resistant epilepsy was defined as failure of adequate trials of
2 tolerated and appropriately chosen and used antiepileptic
drug schedules to achieve sustained seizure freedom.25 Sev-
ere epilepsy was defined as (1) modified Engel class 3 or
higher; (2) history of status epilepticus (SE); (3) history of
ESES; and/or (4) drug-resistant epilepsy.
The neurodevelopmental outcome was assessed at the last
visit to child neurologist by 3 pediatric neurologists (R.L,
S.L., and/or A.K.) according to the Pediatric Stroke Out-
come Measure (PSOM). PSOM is an objective structured
measure of neurological status after stroke in children,
which contains 5 subscales: right sensorimotor, left sensori-
motor, language production, language comprehension, and
cognitive/behavioral performance. Each subscale yields a
deficit severity score: 0 (no deficit), 0.5 (mild deficit, nor-
mal function), 1 (moderate deficit, impaired function), and
2 (severe deficit, missing function).26 Children with unilat-
eral moderate or severe sensorimotor impairment were con-
sidered to have hemiparesis (e.g., cerebral palsy, CP).
Statistical analyses
For statistical analysis, SAS version 8.02 and R version
3.1.2 were used. Statistical comparisons between normally
distributed continuous variables were performed with Stu-
dent’s t-test, whereas for asymmetric continuous variables
nonparametric tests, such as Mann-Whitney U-test were
used. Kolmogorov-Smirnov criterion was used for the
assessment of normality. To compare proportions (qualita-
tive variables), the chi-square test and the Fisher’s exact test
(expected values <5) were used. Odds ratio (OR) with 95%
confidence interval (CI) was used to measure the strength of
the association. All p-values were two-sided, and differ-
ences were considered statistically significant if the p-
values were <0.05. We used the Kaplan-Meier estimation of
the proportion of subjects at any point during follow-up.
Age at epilepsy diagnosis was used for calculating cumula-
tive incidence. Stepwise multiple logistic regression analy-
sis was performed to determine independent variables
associated with poststroke epilepsy. Variables associated
with epilepsy in the univariate analysis (p-value of <0.10)
were included in the multivariate analysis. We controlled
the false discovery rate (FDR) to be lower than 5% by using
the linear step-up procedure27 for multiple tests. Benjamini-
Hochberg critical values were calculated as (i/m)Q, where i
is the rank in an ascending list of p-values, m is the total
number of tests, and Q is an FDR of 0.05. Only the p-values
that were below the adjusted FDR significance threshold




The final study group consisted of 73 children with peri-
natal stroke (39 boys, 34 girls), of these 27 children had
neonatal and 46 presumed perinatal stroke. Fifty-six chil-
dren (77%) were from southern and eastern parts of Estonia
and 17 children from the rest of Estonia. Most children were
born at term, whereas 9 of 73 children were born preterm
from 34 to 36 weeks of gestation and 4 children were born
postterm (≥42 gestational weeks). Patients’ characteristics
according to the stroke subtypes are shown in Table 1.
The most common symptoms of neonatal AIS, AHS, or
CSVT were changes in consciousness (lethargy or irritabil-
ity, 20/27), changes in muscular tone (mainly hypotonic,
12/27), respiratory problems (9/27), and feeding difficulties
(8/27). Neonatal seizures occurred in nearly half of the
neonatal stroke cases (12/27, 44%; see Table 1), focal in 11
cases and generalized in one case. The clinical signs leading
to suspicion of stroke in those without neonatal seizures
were irritability (6), lethargy (5), respiratory difficulties
without a lung disease (2), and apneas (1). Median age at
onset of neonatal seizures was 2 days (Interquartile range
[IQR] 1.5–2.5 days) among children with AIS and 13 days
(IQR 11.5–17.5 days) among children with HS. EEG was
performed during the neonatal period in 11 of 12 cases with
clinical suspicion of neonatal seizures at average of
2.4 days (range 1–9 days) after clinically observed seizure
onset and to 4 of 15 without clinical suspicion of seizures at
an average of 3.0 days (range 0–10 days) after birth.
Epileptiform activity on EEG with a minimum duration of
10 seconds was found in 8 of 12 of the neonates with previ-
ously clinically reported seizures, but in none of the neo-
nates without clinical seizures. Neonatal seizures were
treated with phenobarbital in all cases; the median duration
of treatment was 3.5 months (range 6 days to 11 months).
Hemiparesis was the presenting symptom of presumed
perinatal stroke in all cases except for one with delayed
milestones and one with focal seizures (both children had
AIS). The diagnosis of presumed perinatal stroke, based on
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the first MRI (38/46) or CT (8/46), was established at an
average of 28 months (median 25 months, range 2–
114 months), with no significant differences between pre-
sumed AIS and PVI.
For radiological analyses, MRI was available in 71 cases
and CT only in 2 cases. From children with AIS, the infarc-
tion involved the middle cerebral artery territory in 26 of 28
of the cases and the posterior cerebral artery territory in 2
cases (both children with neonatal AIS). The characteristics
of brain lesions are given in Table 1. Intraparenchymal
hemorrhage was present in 7 of 10 of children with neonatal
HS, and in 3 of 10 cases, stage III unilateral intraventricular
hemorrhage was diagnosed. Three children had CSVT: one
child had thrombosis of the transversal and sigmoid sinus
with hemorrhagic infarction of the thalamus, the other had
thrombosis of the superficial sagittal sinus with hemor-
rhagic infarction of the frontal lobe, and the third child had
thrombosis of the superficial sagittal sinus and left transver-
sal sinus without parenchymal involvement.
Coagulation profile was performed in 61 of 73 cases and
revealed some pathology in 25 of 61 cases (41%). The most
frequent findings were increased level of lipoprotein a (6),
mild hyperhomocysteinemia (4), methylenetetrahydrofolate
reductase C677T homozygous mutation (4), and activated
protein C resistance without factor V Leiden mutation (4).
Mean time at follow-up was 9.45 years (median
8.6 years, range 24–249 months), without significant dif-
ferences between vascular subgroups.
Epilepsy after perinatal stroke
At follow-up, epilepsy was diagnosed in 21 (29%) of 73
children, most of whom had AIS (17/21, 81%, see Table 2).
To calculate a population-based prevalence of epilepsy in
children with perinatal stroke, 56 children from only the
southern and eastern parts of Estonia were included. Among
them, 16 developed epilepsy (16/56, 29%). Poststroke
epilepsy rate was highest among children with neonatal AIS
(10/14, 71%, see Table 2).
The average age at epilepsy diagnosis was 61 months
(median 50 months, range 1 month to 18.4 years). The
diagnosis of epilepsy was established during the first year of
life in 5 of 21 children (24%), during the first 5 years in 13
of 21 children (62%), and during the first 10 years in 18 of
21 children (86%). Only 3 children were diagnosed with
epilepsy after 10 years of life (3/21, 14%); all of them had
neonatal AIS. The 5-year cumulative poststroke epilepsy
risk according to the Kaplan-Meier estimator was 18%
(95% CI 8.1–26.9%), and 18-year cumulative risk was
40.8% (95% CI 20.7–55.9%); see Figure 1.
Most of the children had focal seizures (17/21), but one
child with neonatal AIS had infantile spasms (Figure 2).
Three children with epilepsy diagnosis did not have clini-
cally detectable seizures; the diagnosis was based on the
focal epileptiform activity in EEG and significant cognitive
and/or behavioral deficit. Six children were started on medi-
cation after the first seizure (4 children with neonatal AIS
and 2 children with presumed AIS). Among them, 4 chil-
dren did not have subsequent seizures during the follow-up
period (2 children with neonatal AIS and 2 children with
presumed AIS). Febrile seizures occurred in 2 children: one
child with neonatal HS at the age of 17 months and one
child with presumed AIS at the age of 9 months – both chil-
dren had also afebrile epileptic seizures.
In 13 of 21 cases, epilepsy was controlled with
monotherapy: valproate in 6, oxcarbazepine or carba-
mazepine in 4, and topiramate, lamotrigine, and leve-
tiracetam in single cases. The first drug was valproate
in 10 cases, oxcarbazepine or carbamazepine in 9, topi-
ramate in one, and lamotrigine in one. The other drugs
used were levetiracetam, clonazepam, clobazam, and
prednisone. None of the children received nonmedical
antiepileptic treatment.




N = 73 (%)
AIS
N = 14 (%)
HS
N = 10 (%)
CSVT
N = 3 (%)
AIS
N = 14 (%)
PVI
N = 32 (%)
Males 39 (53) 10 (71) 6 (60) 2 (67) 6 (40) 15 (47)
Mean gestational age (SD) 39.1 (1.8) 39.1 (2.1) 39.3 (1.7) 37.7 (2.1) 38.7 (1.7) 39.3 (1.7)
Mean birth weight (SD) 3,326 (601.3) 3,643 (497.8) 3,377 (681.5) 3,063 (119.7) 3,106 (652.2) 3,302 (587.9)
1-minute Apgar scores: mean (SD) 7.5 (1.7) 6.6 (2.1) 7.4 (1.2) 8 (0) 6.7 (2.3) 8.1 (1.2)
5-minute Apgar scores: mean (SD) 8.4 (1.2) 7.5 (1.9) 8.1 (1.2) 8.3 (0.6) 8.4 (0.9) 9.0 (0.6)
Cesarean section 24 (33) 7 (50) 3 (27) 8 (57) 6 (19)
Emergency 16 3 1 0 7 5
Neonatal seizures 12 (16) 7 (50) 4 (40) 1 (33) 0 0
Left predominance of the lesion 45 (62) 13 (93) 4 (40) 0 9 (60) 19 (59)
Bilateral lesions 10 (14) 0 6 (60) 1 (33) 1 (7) 2 (6)
Cortical lesion 36 (50) 14 (100) 7 (70) 1 (33) 14 (100) 0
Large lesion size 35 (48) 10 (71) 3 (30) 0 7 (50) 15 (47)
AIS, arterial ischemic stroke; HS, hemorrhagic stroke; CSVT, cerebral sinovenous thrombosis; PVI, periventricular venous infarction; and SD, standard devia-
tion.
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Statistical analysis did not reveal any significant dif-
ferences in epilepsy course and severity within different
subgroups (see Table 2). However, there was a ten-
dency for children with PVI to more frequently have
more severe and drug-resistant epilepsy as well as
ESES compared to other subtypes (Table 2). Detailed
information about children with ESES and ESES spec-
trum disorder is shown in Table 3. One child with














Median (IQR) follow-up time (months) 123 (75–174) 96.5 (49–108) 58 (53–70) 153.5 (86–200) 102 (63.5–150) 0.3046
Mean total PSOM score (SD) 3.2 (2.1) 1.5 (1.7) 0.5 (0.5) 2.5 (1.4) 2.3 (1.6) 0.0321
Hemiparesis 8 (57%) 2 (20%) 0 11 (79%) 30 (94%) <0.0001c,d,e
Expressive language disorderb 7 (50%) 2 (10%) 0 4 (29%) 6 (19%) 0.1887
Comprehensive language disorderb 5 (36%) 0 0 1 (7%) 4 (13%) 0.0871
Cognitive deficit according to PSOMb 4 (29%) 2 (20%) 0 3 (21%) 5 (16%) 0.7477
Epilepsy 10 (71%) 2 (20%) 0 7 (50%) 2 (6%) <0.0001c,e,f
Median age (IQR) at epilepsy onset (months) 66.5 (9–129) 26.5 (3–50) NA 53.0 (18–36) 24.5 (13–36) 0.5243
Drug-resistant epilepsy 0 0 NA 3 (43%) 2 (100%) 0.0053
Engel class at last visit
Class 0 1 (10%) 0 2 (29%) 1 (50%)
Class 1 7 (70%) 1 (50%) NA 3 (43%) 1 (50%)
Class 2 2 (20%) 0 0 0
Class 3 0 1 (50%) 2 (29%) 0 0.3486
Status epilepticus 0 0 NA 2 (20%) 1 (50%) 0.0185
ESES 0 1 (50%) NA 1 (14%) 2 (100%) 0.0048
ESES spectrum disorder 2 (20%) 0 NA 1 (14%) 0 0.1183
Severe epilepsy 0 1 (50%) NA 4 (57%) 2 (100%) 0.0027
AIS, arterial ischemic stroke; HS, hemorrhagic stroke; CSVT, cerebral sinovenous thrombosis; PVI, periventricular venous infarction; IQR, interquartile range;
PSOM, pediatric stroke outcome measure; and ESES, electrical status epilepticus in sleep; NA, not applicable.
aModerate-severe.
bFor comparison of 4 groups (CSVT was excluded because of small size), Kruskal-Wallis test or Fischer’s exact test was used followed by Wilcoxon-Mann-
Whitney or Fischer’s exact test to detect pair-wise group differences; statistically significant differences controlled with the false discovery rate are marked with
alphabetical letters: cneonatal AIS vs PVI; dHS vs presumed AIS; eHS vs PVI; fpresumed AIS vs PVI.
Figure 1.
Cumulative incidence of epilepsy among children with perinatal stroke within whole group (A) and stratified by stroke subtype (B)
(Kaplan-Meier estimates). Patients with neonatal arterial ischemic stroke (NAIS) demonstrate the greatest cumulative poststroke epi-
lepsy risk, distributed most evenly throughout childhood, compared to children with presumed arterial ischemic stroke (PAIS), neonatal
hemorrhagic stroke (NHS), and presumed periventricular venous infarction (PPVI).
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presumed PVI had both convulsive SE and ESES at
different time points (Patient 4 in Table 3).
Univariate analyses revealed that children with neonatal
AIS were at the highest risk for epilepsy compared to other
vascular types (Table 4). Children with presumed PVI were
significantly less threatened from epilepsy compared to
other perinatal stroke subtypes. The size and location of the
brain lesion were also important: poststroke epilepsy was
more frequent among children with large lesions involving
multiple cerebral lobes, left-sided stroke, and lesions
Figure 2.
A girl with neonatal arterial ischemic stroke (AIS) and infantile spasms. She was born at term via elective cesarean section because of foo-
tling breech presentation. The Apgar score was 8 in both the first and the fifth minutes. Because of respiratory difficulties, she was admit-
ted to the neonatal intensive care unit on the first day. Brain ultrasound on the second day of life was without pathology. During neonatal
period, she had congenital sepsis and respiratory distress syndrome; clinical seizures were not suspected. Upon discharge at the age of
2 weeks, routine control brain ultrasound revealed a hypointense region in the territory of the left medial cerebral artery. MRI confirmed
the diagnosis of AIS at the age of 1.5 months. At the age of 4 months, she was admitted to the hospital because of serial infantile spasms,
which were controlled by rectal diazepam, and oral anticonvulsive treatment with valproic acid was started. EEG revealed hypsarrhythmia
in the left hemisphere. Neurological exam revealed right-sided spastic hemiparesis. At follow-up (age 6 years 3 months), she is still on
medication, but seizure-free since infancy. She has severe hemiparesis, mild expressive and moderate comprehensive language disorder,
and mild cognitive disorder. She has no thrombotic risk factors other than mildly elevated lipoprotein (40 mg/dL) and low-density
lipoprotein (3.41 mmol/L). (A) Coronal view of cerebral ultrasonography shows a large left-sided hyperechogenic area in the basal ganglia
and in the frontotemporal lobes with enlarged left-sided ventricle at the age of 14 days. (B) Axial view of the T1-weighted MRI image
shows a large left-sided proximal medial cerebral artery stroke with enlarged left ventricle with damage in the thalamus, basal ganglia,
insula, and frontotemporal lobes at the age of 5 months. (C) Sagittal T1-weighted MRI image shows thin corpus callosum at the age of
6 years. (D,E,F) Axial fluid-attenuated inversion recovery (FLAIR), axial T2, and coronal T1 MRI images show left-sided hemiatrophy with
enlarged left ventricle and porencephalic area in the thalamus, basal ganglia, insula, and frontotemporal lobes with surrounding gliosis at
the age of 6 years.
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involving the temporal lobe, parietal lobe, and/or thalamus.
The presentation of stroke with neonatal seizures did not
predict later development of epilepsy (Table 4). In the mul-
tivariable analysis, only cortical lesions (OR 19.7, 95% CI
2.9–133), involvement of thalamus (OR 9.8, 95% CI 1.8–
53.5), and temporal lobe (OR 8.3; 95%CI: 1.8–39.6) were
independently associated with poststroke epilepsy. The area
under the receiver-operating curve of this model was 0.92
(0.85–0.99; p < 0.001).
Discussion
Our study revealed that during a median follow-up of
8.6 years, 29% of children with perinatal stroke developed
poststroke epilepsy. According to the Kaplan-Meier curve,
the cumulative risk of epilepsy by the 18th birthday was
40% among children with perinatal stroke. It is difficult to
compare the total epilepsy prevalence after perinatal stroke
with previous studies, as previous studies have focused on
one or 2 subgroups of perinatal stroke, whereas our study
includes perinatal stroke patients with 5 different vascular
syndromes, enabling subgroup comparison.
Subgroup comparison revealed that children with neona-
tal AIS have the highest prevalence of epilepsy (71%) and
children with presumed PVI the lowest (6%). The second
subgroup with highest risk for epilepsy was presumed AIS
(50%). The main reason that children with AIS are most
often threatened by epilepsy is that the brain cortex is
affected in most AIS cases, whereas it is spared in PVI.4,5
Previous studies have also shown that cortical involvement
predicts the possible development of epilepsy after perina-
tal4 or adult28 stroke.
Our study revealed also several other differences among
perinatal stroke subtypes. Compared to other subtypes, chil-
dren with neonatal AIS have the highest risk for poststroke
epilepsy and have the most equal risk for epilepsy through-
out childhood (Figure 1B) but have the most favorable
course of epilepsy: 80% of children without active seizures
(modified Engel class 0–1) and none with severe epilepsy
(see Table 2). On the other hand, children with presumed
PVI have the lowest risk for poststroke epilepsy, receive the
diagnosis of epilepsy earlier, and have a severe course of
epilepsy (both children with epilepsy had ESES). Also, chil-
dren with neonatal HS receive the diagnosis of epilepsy
early and compared to other subtypes, have intermediate
severity of the course of the epilepsy. Compared to neonatal
AIS, children with presumed AIS have a lower risk for post-
stroke epilepsy but receive the diagnosis earlier and the
course of epilepsy is much worse, as 57% of them have sev-
ere epilepsy.
Few studies have focused on the course of epilepsy after
perinatal stroke. Golomb and described a favorable course
of epilepsy in children with neonatal AIS: 84% of children
without active seizures and 11% with severe epilepsy (mod-
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have reported worse outcome among children with pre-
sumed AIS: 47% of children without active seizures and
24% with severe epilepsy.16 One study combining children
with neonatal and presumed AIS reported an intermediate
outcome: 33% of the children without active seizures and
33% with severe epilepsy.13 Wanigasinhge and colleagues
have shown that the proportion of children with active sei-
zures decreased over time and that the majority of children
with perinatal AIS developed post-stroke epilepsy during
infancy.29 Our study revealed that only one-fourth of the
children received the diagnosis of epilepsy before their first
birthday; however, only 3 children with neonatal AIS were
diagnosed with epilepsy after 10 years of age. In light of
these data, it is important to prospectively follow children
with perinatal stroke, and especially children with neonatal
AIS, for epilepsy throughout childhood and likely up to
adulthood.
According to our study, 2 of 10 of children with neonatal
HS have epilepsy, which is higher than previously reported
by Brouwer et al. (3%),14 but we cannot draw further con-
clusions, as this was the only study we found from the litera-
ture. There were only 3 children with neonatal SVT in our
study group and none of them had epilepsy, but they also
had the lowest follow-up time (median 58 months) in our
study. Because magnetic resonance angiography (MRV) or
CT venography was not performed routinely in earlier years
to term neonates with unilateral intraventricular hemor-
rhage, we cannot exclude the possibility that some of the
patients are misclassified as HS instead of CSVT; however,
none of the 3 patients with hemorrhagic stroke with thala-
mic involvement had epilepsy. A recent meta-analysis
showed that 17–40% of children with neonatal CSVT have
epilepsy.15 Among children with neonatal thalamic hemor-
rhage due to CSVT, 67% of children developed epilepsy
and 33% of them had ESES according to a study by Kersber-
gen.24
Twelve of 27 neonatal stroke patients had neonatal sei-
zures (44%), as did half of the patients with neonatal AIS,
which is less than previously reported (75–89%).10–13 It is
possible that some neonatal seizures were missed because
of lack of continuous EEG monitoring during the neonatal
period in our cohort. Low with coworkers showed in their
recent study that by using continuous multichannel video-
EEG, 78% of seizure events were electrographic-only sei-
zures in newborns with AIS.30 The other reason is that in
many cases EEG was performed later than 3 days from the
onset of stroke symptoms, including clinically suspected
seizures. However, we would also like to underscore that
MRI investigations with suspicion of stroke were performed
in newborns with neurological symptoms other than sei-
zures, which also can explain the lower neonatal seizure fre-
quency in our neonatal study group. EEG was performed as
screening without clinical suspicion of seizures in 4 children
with neonatal stroke, but none of them had epileptiform
activity on EEG.
Most of the previous studies also have not shown the
association between neonatal seizures and epilepsy among
children with perinatal stroke,11,12,29 but a recent study by
Table 4. Univariable analysis of predictive factors for epilepsy after perinatal stroke
Factor
Patients with epilepsy
N = 21 (%)
Patients without epilepsy
N = 52 (%) Odds ratio 95% CI
Male 11 (50) 28 (54) 0.94 0.34–2.60
Neonatal stroke 12 (57) 15 (29) 3.29 1.15–9.42
Neonatal AIS 10 (48) 4 (8) 10.9 2.88–41.3
Neonatal HS 2 (10) 8 (15) 0.58 0.11–2.99
Presumed AIS 7 (33) 7 (13) 3.21 0.80–12.7
Presumed PVI 2 (10) 30 (58) 0.08 0.37–0.02
Neonatal and presumed AIS 17 (81) 11 (21) 15.8 4.42–56.8
Arterial stroke (AIS; HS) 19 (90) 19 (37) 16.5 3.46–78.7
Cortical lesion 19 (90) 18 (35) 17.9 3.75–85.8
Left side of the lesion 17 (81) 28 (54) 3.64 1.08–12.3
Bilateral brain damage 3 (14) 7 (13) 1.07 0.16–5.37
Large stroke 16 (76) 19 (37) 5.56 1.76–17.6
Basal ganglia 9 (43) 11 (21) 2.80 0.94–8.32
Thalamus 17 (81) 26 (50) 4.25 1.26–14.4
Frontal lobe 18 (86) 39 (75) 2.00 0.51–7.9
Parietal lobe 18 (86) 23 (44) 7.57 1.98–28.9
Temporal lobe 15 (71) 5 (10) 23.5 6.27–88.1
Occipital lobe 0 3 (6) p = 0.55
Cerebellum 0 1 (2) p = 1.00
Neonatal seizures 5 (24) 7 (13) 2.01 0.56–7.24
Electroclinical seizures 4 (19) 4 (8) 2.82 0.63–12.6
Neonatal seizures among patients with AIS 4/17 (24) 3/11 (27) 1.22 0.14–9.41
CI, confidence interval; AIS, arterial ischemic stroke; HS, hemorrhagic stroke; PVI, periventricular venous infarction; and IQR, interquartile range.
Bold text indicates a statistically significant correlation.
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Fox and coauthors13 showed that neonatal seizures nearly
triple the risk for remote seizures among children with
neonatal and presumed AIS. In our study, neonatal seizures
did not predict poststroke epilepsy onset, but the lack of
association may be influenced by the fact that we might
have missed some cases of neonatal seizures. On the other
hand, there may be different mechanisms that aggravate
acute seizures compared to poststroke epilepsy. Histopatho-
logical studies have shown that early poststroke seizures are
provoked by metabolic changes, acute glutamate release,
changes in the penumbra zone, and anoxic depolarization,
whereas late-onset seizures are associated with axon sprout-
ing and the progressive formation of new recurrent excita-
tory circuits because of abnormal scar tissue and by the
selective loss of specific inhibitory c-aminobutyric acid
(GABA)ergic interneurons.31
Total anterior circulation infarct, cerebral hemorrhage,
cortical lesions (especially in temporal lobe), large lesions,
and early seizures are most consistently associated with
poststroke epilepsy in adults.28,32 Multivariate analysis in
our study revealed that cortical lesions and involvement of
temporal lobe and thalamus were independently associated
with poststroke epilepsy; these associations have been
shown also in some previous studies of perinatal stroke.4,24
Four children in our cohort developed ESES, and 3 devel-
oped ESES spectrum disorder. In all cases, the size of the
brain lesion was large, affecting multiple lobes including
the temporal lobe and/or the thalamus. It is surprising that
both patients with epilepsy after presumed PVI had ESES.
One of them had COL4A1 mutation and bilateral brain
lesions. This underscores the need for molecular genetic
investigation in children with stroke.
The association between epilepsy and neurodevelopmen-
tal outcome of children with perinatal stroke is still unclear:
Ricci and colleagues did not find any correlation between
cognitive development and epilepsy among children with
neonatal AIS,7 but Wanigasinhge and colleagues have
shown that the mean functioning at school was significantly
lower in the children with presumed AIS and epilepsy than
in those without epilepsy.29 In our study, both poststroke
epilepsy and cognitive deficit occurred most frequently
among children with neonatal AIS, but further studies are
needed to clarify the true association in children with AIS
and also with other vascular syndromes.
This study also has some limitations. To begin with, ours
was a retrospective descriptive study over a 20-year period.
Standardized protocols were not used to diagnose neonatal
seizures or poststroke epilepsy. Therefore, neonatal seizures
may be underdiagnosed, as continuous neonatal EEG was
not available. The high prevalence of poststroke epilepsy
may be influenced by the fact that epilepsy was diagnosed
without overt clinical seizures in some cases. In subgroup
comparisons, small sample sizes may have not produced
significant statistical parameters, even in the presence of a
large effect.
In conclusion, 40% of children with perinatal stroke are
threatened by epilepsy during childhood. Children with dif-
ferent perinatal stroke vascular syndromes have different
risk and course of poststroke epilepsy: for example, children
with neonatal AIS have the highest risk but the most favor-
able course, whereas children with presumed AIS have
lower risk but a much more serious course of poststroke epi-
lepsy. Lesions located in the cortex, thalamus, and/or tem-
poral lobe are most significantly associated with the onset
of poststroke epilepsy. Patients with perinatal stroke, espe-
cially with AIS, need close follow-up to detect epilepsy and
start with antiepileptic treatment in time.
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